Spanish research institution to use Elicera Therapeutics’ iTANK platform
Elicera Therapeutics AB has entered a material transfer agreement with the Josep Carreras Leukaemia Research…
Elicera Therapeutics AB has entered a material transfer agreement with the Josep Carreras Leukaemia Research…
CDF15 cytokine a promising therapeutic target against type 2 diabetes Researchers have conducted a review…
Ewing sarcoma is the second most frequent bone tumor in children, adolescents, and young adults. …
A grant has been awarded to look into the feasibility of bringing to market a…
There’s a lot of research going on around the world, and that means lots of…
Reveal Genomics, S.L. says it has received more validation of HER2DX, the world's first specialized…
This week’s guests on the podcast are Bobby Soni, chief business officer at the BioInnovation…
This week it’s another four interview podcast, and the introduction of a new feature. Our…
CRISPR/Cas9 is a commonly used gene editing technique. CRISPR allows the introduction of a desired…
The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with…
Life sciences organization Biocat says midyear investment in startups in the BioRegion of Catalonia in…
A company developing precision T cell therapies that treat solid tumors announced yesterday (July 21)…